Tel Aviv - Delayed Quote ILA
BioLineRx Ltd. (BLRX.TA)
1.8000
+0.1000
+(5.88%)
At close: April 24 at 5:24:34 PM GMT+3
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-43,873
-43,873
-22,608
-26,240
-23,573
Investing Cash Flow
29,374
29,374
1,444
4,006
-38,224
Financing Cash Flow
20,658
20,658
15,056
20,438
57,749
End Cash Position
10,436
10,436
4,255
10,587
12,990
Interest Paid Supplemental Data
10,387
10,387
1,111
593
682
Capital Expenditure
-54
-54
-297
-316
-97
Issuance of Capital Stock
16,357
16,357
14,089
14,359
50,407
Issuance of Debt
19,223
19,223
--
9,126
--
Repayment of Debt
-14,944
-14,944
-1,988
-3,052
-3,572
Free Cash Flow
-43,927
-43,927
-22,905
-26,556
-23,670
12/31/2021 - 4/4/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LCTX.TA Lineage Cell Therapeutics, Inc.
169.10
+6.62%
ENLV.TA Enlivex Therapeutics Ltd.
337.50
+2.09%
CMMB Chemomab Therapeutics Ltd.
1.2900
+7.50%
OKUR OnKure Therapeutics, Inc.
2.6500
-3.99%
PPBT Purple Biotech Ltd
2.7300
+1.11%
DRTS Alpha Tau Medical Ltd.
2.6400
-0.38%
EPIX ESSA Pharma Inc.
1.8000
+2.27%
MDWD MediWound Ltd.
18.03
+0.33%
LSTA Lisata Therapeutics, Inc.
2.4400
+3.83%
ORMP Oramed Pharmaceuticals Inc.
2.3000
-0.43%